Bioventus Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bioventus Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2024.
  • Bioventus Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 29, 2024 was -$24M, a 552% decline year-over-year.
  • Bioventus Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 29, 2024 was -$42M, a 85.2% increase year-over-year.
  • Bioventus Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$156M, a 1.56% increase from 2022.
  • Bioventus Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$159M, a 919% decline from 2021.
  • Bioventus Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $19.4M, a 18.1% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$42M -$24M -$20.3M -552% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-06
Q1 2024 -$21.7M -$4.57M +$135M +96.7% Jan 1, 2024 Mar 30, 2024 10-Q 2024-05-07
Q4 2023 -$156M -$6.1M +$25.8M +80.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$182M -$7.3M +$101M +93.3% Jul 2, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$283M -$3.68M +$3.57M +49.2% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-06
Q1 2023 -$287M -$139M -$128M -1134% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-07
Q4 2022 -$159M -$31.9M -$31.6M -8672% Oct 2, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$127M -$108M -$107M -10007% Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-07
Q2 2022 -$20M -$7.25M -$3.13M -75.8% Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-08
Q1 2022 -$16.8M -$11.3M -$36.2M -145% Jan 1, 2022 Apr 2, 2022 10-Q 2023-05-16
Q4 2021 $19.4M -$364K -$3.14M -113% Oct 3, 2021 Dec 31, 2021 10-K 2024-03-12
Q3 2021 $22.5M -$1.07M -$9.53M -113% Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-21
Q2 2021 $32M -$4.13M +$1.64M +28.4% Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-12
Q1 2021 $30.4M $24.9M +$14M +128% Jan 1, 2021 Apr 3, 2021 10-Q 2022-05-11
Q4 2020 $16.4M $2.78M Sep 27, 2020 Dec 31, 2020 10-K 2023-03-31
Q3 2020 $8.46M Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-10
Q2 2020 -$5.77M Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-11
Q1 2020 $10.9M Jan 1, 2020 Mar 28, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.